Confronting Risk About Antidepressants for Children

Antonuccio, David
November 2007
Ethical Human Psychology & Psychiatry;Fall2007, Vol. 9 Issue 3, p147
Academic Journal
The author discusses the importance of studying the benefits and risks of psychotropic medications for depression in children based on what he learned from Doctor Peter Breggin. He notes that Breggin was articulate and passionate in his delineation of the hazards of antidepressants when he testified at the first U.S. Food and Drug Administration (FDA) hearings on antidepressant-induced suicidality in children in February 2004. He emphasizes the need to have a balanced access to information about the benefits and risks of psychotropic medication.


Related Articles

  • A Suicide Warning. Stein, Lisa // U.S. News & World Report;2/16/2004, Vol. 136 Issue 6, p15 

    Reports that a U.S. government panel advised the Food and Drug Administration to require labels on antidepressants warning parents that the drugs might cause suicidal behavior in children and teenagers. Why the advisory committee said the warning is needed for drugs like Paxil and Zoloft; Topic...

  • Black box warnings to be added to all antidepressants.  // Drug Topics;10/25/2004, Vol. 148 Issue 20, p8 

    This article reports that a Public Health Advisory has been issued by the U.S. Food and Drug Administration announcing its multi-pronged strategy to warn the public about the increased risk of suicidality in children and adolescents being treated with antidepressant medications. The agency is...

  • THE BEST MEDICINE. Wingert, Pat // Newsweek;9/27/2004, Vol. 144 Issue 13, p88 

    Reports that the U.S. Food and Drug Administration panel advised adding warnings to antidepressants because they cause two to three percent of children to become suicidal. Risks of not treating depressed children; Views of National Institutes of Health researcher Dr. John March; Topic of...

  • TEENS AND DEPRESSION.  // Time International (South Pacific Edition);8/30/2004, Issue 34, p75 

    The article reports on an announcement by the U.S. Food and Drug Administration (FDA) that a new analysis of clinical data supports the idea that some antidepressant drugs increase the risk of suicide in teens. A decision by the PDA on new warning labels will probably come in September 2004....

  • Antidepressants for Children. Rlotter, Jule // Townsend Letter for Doctors & Patients;Oct2004, Issue 255, p20 

    Reports on the increase incidents of suicidal attempts and suicidal thoughts among patients under eighteen years old using antidepressant Paxil of GlaxoSmithKline PLC. Extended investigation of pediatric antidepressants by U. S. Food & Drug Administration; Uncertainty of the critics regarding...

  • ANTIDEPRESSANT UPS SUICIDE RISK IN ADULTS.  // Ecologist;Jul/Aug2006, Vol. 36 Issue 6, p14 

    The article reports that Seroxat can cause adults as well as children to become suicidal. Seroxat is the best-selling anti-depressant in the Great Britain. GlaxoSmithKline (GSK), manufacturer of Seroxat, has long been denying that there was a problem wit the drug. GSK was forced to admit the...

  • FDA to review risks of antidepressants in adults. Lenzer, Jeanne // BMJ: British Medical Journal (International Edition);10/9/2004, Vol. 329 Issue 7470, p816 

    Reports that the United States Food and Drug Administration has announced that it will examine whether antidepressants pose a similar risk of increased suicidal thoughts among adults as they do for children. Comments about the review of adult data and antidepressant use; How a recent study led...

  • Antidepressants And Kids: Hearings Put FDA In The Hot Seat. Hurley, Mary Lou // RN;Oct2004, Vol. 67 Issue 10, p78 

    Reports antidepressants increase children's suicidal thoughts and behaviors. Need for antidepressants in the U.S. to carry a black box warning; Position of the U.S. Food and Drug Administration.

  • The SSRI Trials in Children: Disturbing Implications for Academic Medicine. Leo, Jonathan // Ethical Human Psychology & Psychiatry;Spring2006, Vol. 8 Issue 1, p29 

    The recent announcement by the Food and Drug Administration (FDA) requiring pharmaceutical companies to warn patients about the increased likelihood of suicidal thoughts when taking antidepressants was largely due to the recent availability of data that had gone unreported in the original...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics